Bone marrow explant needle
Australia TGA ARTG Registered Device · Horten Medical Pty Ltd · Ranfac Corporation · Class IIa · Started August 03, 2022
Good Name: Horten Medical Pty Ltd - Bone marrow explant needle
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- August 03, 2022
- Effective Date
- August 03, 2022
- Country
- United States of America
- Address
- 30 Doherty Avenue, AVON, MA, 02322
Intended to be used for the explant of bone marrow samples.
Access comprehensive regulatory information for Bone marrow explant needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Horten Medical Pty Ltd, manufactured by Ranfac Corporation in United States of America. The device registration started on August 03, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.